Sándor, Gyöngyvér Orsolya
Farkas, Gyöngyi
Székely, Gábor
Ágoston, Péter
Jorgo, Kliton
Gesztesi, László
Major, Tibor
Pesznyák, Csilla
Herein, András
Stelczer, Gábor
Mihály, Dalma
Fröhlich, Georgina
Jurányi, Zsolt
Takácsi-Nagy, Zoltán
Polgár, Csaba
Kocsis, Zsuzsa S.
Funding for this research was provided by:
National Research, Development and Innovation Fund (2022-2.1.1-NL-2022-00010, 2020-1.1.6-JÖVŐ-2021-00008, 2020-1.1.6-JÖVŐ-2021-00008, 2022-2.1.1-NL-2022-00010, 2022-2.1.1-NL-2022-00010, 2022-2.1.1-NL-2022-00010, 2022-2.1.1-NL-2022-00010, 2022-2.1.1-NL-2022-00010, 2022-2.1.1-NL-2022-00010)
Article History
Received: 30 August 2024
Accepted: 26 November 2024
First Online: 9 January 2025
Declarations
:
: The authors declare no competing interests.
: This work was supported by the National Research, Development and Innovation Fund of the Ministry of Culture and Innovation under the National Laboratories Program (National Tumor Biology Laboratory (2022 − 2.1.1-NL-2022-00010)); the Hungarian Thematic Excellence Program (TKP2021-EGA-44) and the Investment in the Future (Development of Innovative Cancer Diagnostic and Therapeutic Procedures at the National Institute of Oncology (2020 − 1.1.6-JÖVŐ-2021-00008)) Grant Agreements with the National Research, Development and Innovation Office.